Sonim Technologies, Inc. (SONM) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.25
Day's range
$4.64

DNA X Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
UBS GROUP AG 05/05/2026 36.22 K $145.96 K   317.17% 5.01%
C2C WEALTH MANAGEMENT, LLC 04/20/2026 20.00 K $80.60 K   100.00% 2.77%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 14.80 K $59.65 K   100.00% 2.05%
BLACKROCK, INC. 05/13/2026 14.01 K $56.44 K   0.00% 1.94%
05/15/2026 4.89 K $19.72 K   100.00% 0.68%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 4.50 K $18.12 K   100.00% 0.62%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2026 661 $2.66 K   100.00% 0.09%
SBI SECURITIES CO., LTD. 04/28/2026 214 $862   0.00% 0.03%
DANSKE BANK A/S 05/12/2026 4 $16   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 05/18/2026 0 $0   -100.00% 0.00%
CANNELL CAPITAL LLC 05/15/2026 0 $0   -100.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 0 $0   -100.00% 0.00%
POTOMAC CAPITAL MANAGEMENT, INC. 05/14/2026 0 $0   -100.00% 0.00%

DNA X Inc. institutional Ownership - FAQ's

During the previous two years, 15 institutional investors and hedge funds held shares of DNA X Inc.. The most heavily invested institutionals were:

UBS Group AG: 36,219

C2C Wealth Management, LLC: 20,000

GEODE CAPITAL MANAGEMENT, LLC: 14,802

BlackRock, Inc.: 14,006

VANGUARD FIDUCIARY TRUST CO: 4,496

Tower Research Capital LLC (TRC): 661

13.19% of DNA X Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 90.50 K shares in the last 24 months. This purchase volume represents approximately $397.30 K in transactions.